Hancock Whitney’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,003
Closed -$309K 822
2020
Q4
$309K Buy
4,003
+1
+0% +$77 0.01% 638
2020
Q3
$295K Buy
4,002
+150
+4% +$12K 0.01% 634
2020
Q2
$283K Sell
3,852
-1,564
-29% -$123K 0.01% 634
2020
Q1
$313K Buy
5,416
+1,332
+33% +$92.6K 0.01% 630
2019
Q4
$321K Sell
4,084
-2,567
-39% -$189K 0.01% 670
2019
Q3
$455K Sell
6,651
-731
-10% -$49.1K 0.01% 616
2019
Q2
$586K Buy
+7,382
New +$585K 0.02% 584

Other funds holding USNA

Hancock Whitney's USNA Position: Q1 2021 in Review

Hancock Whitney sold out of Usana Health Sciences (USNA) in Q1 2021, closing a stake of 4,003 shares — an estimated $309K sold.

Hancock Whitney first reported a position in USNA in Q2 2019 and held it in 7 quarters. The position peaked at $586K in Q2 2019. 198 funds tracked by Wall St. Rank hold USNA as of Q1 2021.

  • Hancock Whitney reported no remaining Usana Health Sciences position as of Q1 2021 after selling out during the quarter.
  • Hancock Whitney sold 4,003 Usana Health Sciences shares in Q1 2021, an estimated $309K.
  • Hancock Whitney first reported a position in Usana Health Sciences in Q2 2019 and held it in 7 quarters.
  • Hancock Whitney's Usana Health Sciences position peaked at $586K in Q2 2019.
  • 198 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2021.

Based on Hancock Whitney's 13F filing for Q1 2021, filed 14 May 2021.